Protein transamidation by transglutaminase 2 in cells: A disputed Ca 2+-dependent action of a multifunctional protein

FEBS Journal

Volumn 278, Issue 24, 2011, Pages 4717-4739

  Király, Róbert ^a   Demény, Máté Á ^a   Fésüs, László ^a  

^a UNIVERSITY OF DEBRECEN   (Hungary)

Author keywords

Ca 2+ binding sites and regulation; intracellular activation; pathologic conditions; physiological processes; protein transamidation; splice variants; substrates; transglutaminase 2

Indexed keywords

6 (GAMMA GLUTAMYL)LYSINE; ALPHA SYNUCLEIN; AMPA RECEPTOR; BETA CRYSTALLIN; CALCIUM CHANNEL L TYPE; CALCIUM ION; CYCLIC GMP; CYTOKERATIN 18; CYTOKERATIN 8; GUANOSINE 5' O (3 THIOTRIPHOSPHATE); GUANOSINE DIPHOSPHATE; GUANOSINE PHOSPHATE; GUANOSINE TRIPHOSPHATE; HUNTINGTIN; INOSITOL 1,4,5 TRISPHOSPHATE RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; POLYAMINE; PROTEIN DISULFIDE ISOMERASE; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE 2; PROTEIN KINASE; REACTIVE OXYGEN METABOLITE; RYANODINE RECEPTOR; VOLTAGE GATED CALCIUM CHANNEL;

ALTERNATIVE RNA SPLICING; ALZHEIMER DISEASE; APOPTOSIS; BINDING SITE; CALCIUM BINDING; CALCIUM HOMEOSTASIS; CALCIUM TRANSPORT; CATARACT; CELL ACTIVITY; CELL DIFFERENTIATION; CELL STRESS; CHANNEL GATING; CONCENTRATION (PARAMETERS); ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME REGULATION; ENZYME STRUCTURE; HUMAN; HUNTINGTON CHOREA; LIPID PEROXIDATION; NONHUMAN; NUCLEOTIDE SEQUENCE; OXIDATIVE STRESS; PARKINSON DISEASE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN HYDROLYSIS; PROTEIN INTERACTION; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; PROTEIN TRANSAMIDATION; RECEPTOR BINDING; REVIEW;

AGING; ALTERNATIVE SPLICING; ALZHEIMER DISEASE; AMINO ACID SEQUENCE; ANIMALS; BINDING SITES; CALCIUM; CROSS-LINKING REAGENTS; ENZYME ACTIVATION; EXTRACELLULAR SPACE; GTP-BINDING PROTEINS; GUANOSINE TRIPHOSPHATE; HUMANS; HUNTINGTON DISEASE; MOLECULAR SEQUENCE DATA; OXIDATION-REDUCTION; PROTEIN PROCESSING, POST-TRANSLATIONAL; SEQUENCE ALIGNMENT; TRANSGLUTAMINASES;

EID: 82755161784     PISSN: 1742464X     EISSN: 17424658     Source Type: Journal    
DOI: 10.1111/j.1742-4658.2011.08345.x     Document Type: Review

References (176)

1. Lorand L, &, Graham RM, (2003) Transglutaminases: crosslinking enzymes with pleiotropic functions. Nat Rev Mol Cell Biol 4, 140-156. (Pubitemid 36172696)
2. Fesus L, &, Piacentini M, (2002) Transglutaminase 2: an enigmatic enzyme with diverse functions. Trends Biochem Sci 27, 534-539. (Pubitemid 35279599)
3. Komáromi I, Bagoly Z, &, Muszbek L, (2011) Factor XIII: novel structural and functional aspects. J Thromb Haemost 9, 9-20.
4. Steinert PM, &, Marekov LN, (1999) Initiation of assembly of the cell envelope barrier structure of stratified squamous epithelia. Mol Biol Cell 10, 4247-4261.
5. Nakaoka H, Perez DM, Baek KJ, Das T, Husain A, Misono K, Im MJ, &, Graham RM, (1994) Gh: a GTP-binding protein with transglutaminase activity and receptor signaling function. Science 264, 1593-1596.
6. Mishra S, &, Murphy LJ, (2004) Tissue transglutaminase has intrinsic kinase activity: identification of transglutaminase 2 as an insulin-like growth factor-binding protein-3 kinase. J Biol Chem 279, 23863-23868. (Pubitemid 38725242)
7. Hasegawa G, Suwa M, Ichikawa Y, Ohtsuka T, Kumagai S, Kikuchi M, &, Saito Y, (2003) A novel function of tissue-type transglutaminase: protein disulphide isomerase. Biochem J 373, 793-803. (Pubitemid 36981089)
8. Belkin AM, (2011) Extracellular TG2: emerging functions and regulation. FEBS J 278, 4704-4716.
9. 2-terminal beta-sandwich domain of tissue transglutaminase. J Biol Chem 280, 23675-23683. (Pubitemid 40884849)
10. Peng X, Zhang Y, Zhang H, Graner S, Williams JF, Levitt ML, &, Lokshin A, (1999) Interaction of tissue transglutaminase with nuclear transport protein importin-alpha3. FEBS Lett 446, 35-39. (Pubitemid 29127245)
11. 2+-binding sites of human transglutaminase 2 characterized by site-directed mutagenesis. FEBS J 276, 7083-7096.
12. Belkin AM, Zemskov EA, Hang J, Akimov SS, Sikora S, &, Strongin AY, (2004) Cell-surface-associated tissue transglutaminase is a target of MMP-2 proteolysis. Biochemistry 43, 11760-11769. (Pubitemid 39277621)
13. Zemskov EA, Mikhailenko I, Hsia RC, Zaritskaya L, &, Belkin AM, (2011) Unconventional secretion of tissue transglutaminase involves phospholipid-dependent delivery into recycling endosomes. PLoS ONE 6, e19414.
14. Stamnaes J, Pinkas DM, Fleckenstein B, Khosla C, &, Sollid LM, (2010) Redox regulation of transglutaminase 2 activity. J Biol Chem 285, 25402-25409.
15. Clarke DD, Mycek MJ, Neidle A, &, Waelsch H, (1959) The incorporation of amines into protein. Arch Biochem Biophys 79, 338-354.
16. Folk JE, &, Chung S, (1973) Molecular and catalytic properties of transglutaminases. Adv Enzymol Relat Areas Mol Biol 38, 109-191.
17. Bergamini CM, Signorini M, &, Poltronieri L, (1987) Inhibition of erythrocyte transglutaminase by GTP. Biochim Biophys Acta 916, 149-151. (Pubitemid 17151217)
18. Bergamini CM, (1988) GTP modulates calcium binding and cation-induced conformational changes in erythrocyte transglutaminase. FEBS Lett 239, 255-258. (Pubitemid 18263458)
19. Gomis R, Sener A, Malaisse-Lagae F, &, Malaisse WJ, (1983) Transglutaminase activity in pancreatic islets. Biochim Biophys Acta 760, 384-388. (Pubitemid 14241226)
20. Bungay PJ, Potter JM, &, Griffin M, (1984) The inhibition of glucose-stimulated insulin secretion by primary amines. A role for transglutaminase in the secretory mechanism. Biochem J 219, 819-827. (Pubitemid 14141742)
21. Hand D, Bungay PJ, Elliott BM, &, Griffin M, (1985) Activation of transglutaminase at calcium levels consistent with a role for this enzyme as a calcium receptor protein. Biosci Rep 5, 1079-1086. (Pubitemid 16141515)
22. 2+-binding domain. J Biol Chem 273, 15879-15882. (Pubitemid 28311347)
23. Casadio R, Polverini E, Mariani P, Spinozzi F, Carsughi F, Fontana A, Polverino de Laureto P, Matteucci G, &, Bergamini CM, (1999) The structural basis for the regulation of tissue transglutaminase by calcium ions. Eur J Biochem 262, 672-679. (Pubitemid 29291023)
24. Di Venere A, Rossi A, De Matteis F, Rosato N, Agrò AF, &, Mei G, (2000) Opposite effects of Ca(2+) and GTP binding on tissue transglutaminase tertiary structure. J Biol Chem 275, 3915-3921. (Pubitemid 30094616)
25. Humphrey W, Dalke A, &, Schulten K, (1996) VMD: visual molecular dynamics. J Mol Grap 14, 33-38. (Pubitemid 26152973)
26. Iismaa SE, Holman S, Wouters MA, Lorand L, Graham RM, &, Husain A, (2003) Evolutionary specialization of a tryptophan indole group for transition-state stabilization by eukaryotic transglutaminases. Proc Natl Acad Sci USA 100, 12636-12641. (Pubitemid 37339951)
27. Murthy SN, Lomasney JW, Mak EC, &, Lorand L, (1999) Interactions of G(h)/transglutaminase with phospholipase Cdelta1 and with GTP. Proc Natl Acad Sci USA 12, 11815-11819. (Pubitemid 29502815)
28. Murthy SN, Iismaa S, Begg G, Freymann DM, Graham RM, &, Lorand L, (2002) Conserved tryptophan in the core domain of transglutaminase is essential for catalytic activity. Proc Natl Acad Sci USA 99, 2738-2742. (Pubitemid 34240530)
29. Pinkas DM, Strop P, Brunger AT, &, Khosla C, (2007) Transglutaminase 2 undergoes a large conformational change upon activation. PLoS Biol 5, e327.
30. Liu S, Cerione RA, &, Clardy J, (2002) Structural basis for the guanine nucleotide-binding activity of tissue transglutaminase and its regulation of transamidation activity. Proc Natl Acad Sci USA 99, 2743-2747. (Pubitemid 34240531)
31. Han BG, Cho JW, Cho YD, Jeong KC, Kim SY, &, Lee BI, (2010) Crystal structure of human transglutaminase 2 in complex with adenosine triphosphate. Int J Biol Macromol 47, 190-195.
32. Ahvazi B, Boeshans KM, Idler W, Baxa U, &, Steinert PM, (2003) Roles of calcium ions in the activation and activity of the transglutaminase 3 enzyme. J Biol Chem 278, 23834-23841. (Pubitemid 36830209)
33. Ahvazi B, Boeshans KM, &, Rastinejad F, (2004) The emerging structural understanding of transglutaminase 3. J Struct Biol 147, 200-207. (Pubitemid 38757515)
34. Begg GE, Carrington L, Stokes PH, Matthews JM, Wouters MA, Husain A, Lorand L, Iismaa SE, &, Graham RM, (2006) Mechanism of allosteric regulation of transglutaminase 2 by GTP. Proc Natl Acad Sci USA 103, 19683-19688. (Pubitemid 46037492)
35. 2+-binding helix-loop-helix EF-hand motifs. Biochem J 405, 199-221. (Pubitemid 47075156)
36. Zelensky AN, &, Gready JE, (2005) The C-type lectin-like domain superfamily. FEBS J 272, 6179-6217. (Pubitemid 41815610)
37. Lemmon MA, (2008) Membrane recognition by phospholipid-binding domains. Nat Rev Mol Cell Biol 9, 99-111. (Pubitemid 351158910)
38. Smallridge RS, Whiteman P, Werner JM, Campbell ID, Handford PA, &, Downing AK, (2003) Solution structure and dynamics of a calcium binding epidermal growth factor-like domain pair from the neonatal region of human fibrillin-1. J Biol Chem 278, 12199-12206. (Pubitemid 36800200)
39. Bergamini CM, Dondi A, Lanzara V, Squerzanti M, Cervellati C, Montin K, Mischiati C, Tasco G, Collighan R, Griffin M, et al. (2010) Thermodynamics of binding of regulatory ligands to tissue transglutaminase. Amino Acids 39, 297-304.
40. Porzio O, Massa O, Cunsolo V, Colombo C, Malaponti M, Bertuzzi F, Hansen T, Johansen A, Pedersen O, Meschi F, et al. (2007) Missense mutations in the TGM2 gene encoding transglutaminase 2 are found in patients with early-onset type 2 diabetes. Mutation in brief no. 982. Online. Hum Mutat 28, 1150.
41. Bernassola F, Federici M, Corazzari M, Terrinoni A, Hribal ML, De Laurenzi V, Ranalli M, Massa O, Sesti G, McLean WH, et al. (2002) Role of transglutaminase 2 in glucose tolerance: knockout mice studies and a putative mutation in a MODY patient. FASEB J 16, 1371-1378. (Pubitemid 34913309)
42. Achyuthan KE, &, Greenberg CS, (1987) Identification of a guanosine triphosphate-binding site on guinea pig liver transglutaminase. Role of GTP and calcium ions in modulating activity. J Biol Chem 262, 1901-1906.
43. Takeuchi Y, Birckbichler PJ, Patterson MK Jr, &, Lee KN, (1992) Putative nucleotide binding sites of guinea pig liver transglutaminase. FEBS Lett 307, 177-180.
44. Lai TS, Slaughter TF, Peoples KA, Hettasch JM, &, Greenberg CS, (1998) Regulation of human tissue transglutaminase function by magnesium-nucleotide complexes. Identification of distinct binding sites for Mg-GTP and Mg-ATP. J Biol Chem 273, 1776-1781. (Pubitemid 28133710)
45. Lai TS, Hausladen A, Slaughter TF, Eu JP, Stamler JS, &, Greenberg CS, (2001) Calcium regulates S-nitrosylation, denitrosylation, and activity of tissue transglutaminase. Biochemistry 40, 4904-4910. (Pubitemid 32332535)
46. Clapham DE, (2007) Calcium signaling. Cell 131, 1047-1058. (Pubitemid 350258556)
47. 2+ and nucleotides. Biochem J 313, 803-808.
48. Siegel M, Strnad P, Watts RE, Choi K, Jabri B, Omary MB, &, Khosla C, (2008) Extracellular transglutaminase 2 is catalytically inactive, but is transiently activated upon tissue injury. PLoS ONE 3, e1861.
49. Nanda N, Iismaa SE, Owens WA, Husain A, Mackay F, &, Graham RM, (2001) Targeted inactivation of Gh/tissue transglutaminase II. J Biol Chem 276, 20673-20678.
50. De Laurenzi V, &, Melino G, (2001) Gene disruption of tissue transglutaminase. Mol Cell Biol 21, 148-155.
51. Fesus L, &, Tarcsa E, (1989) Formation of N epsilon-(gamma-glutamyl)- lysine isodipeptide in Chinese-hamster ovary cells. Biochem J 263, 843-848. (Pubitemid 19276464)
52. Harsfalvi J, Tarcsa E, Udvardy M, Zajka G, Szarvas T, &, Fesus L, (1992) Presence and possible origin of epsilon(gamma-glutamyl)lysine isodipeptide in human plasma. Thromb Haemost 67, 60-62.
53. Nemes Z, Fésüs L, Egerházi A, Keszthelyi A, &, Degrell IM, (2001) N(epsilon)(gamma-glutamyl)lysine in cerebrospinal fluid marks Alzheimer type and vascular dementia. Neurobiol Aging 22, 403-406. (Pubitemid 32510911)
54. Zhang J, Lesort M, Guttmann RP, &, Johnson GV, (1998) Modulation of the in situ activity of tissue transglutaminase by calcium and GTP. J Biol Chem 273, 2288-2295. (Pubitemid 28069282)
55. Begg GE, Holman SR, Stokes PH, Matthews JM, Graham RM, &, Iismaa SE, (2006) Mutation of a critical arginine in the GTP-binding site of transglutaminase 2 disinhibits intracellular cross-linking activity. J Biol Chem 281, 12603-12609. (Pubitemid 43855349)
56. Ruan Q, Tucholski J, Gundemir S, &, Johnson Voll GV, (2008) The differential effects of R580A mutation on transamidation and GTP binding activity of rat and human type 2 transglutaminase. Int J Clin Exp Med 1, 248-259.
57. Piacentini M, Martinet N, Beninati S, &, Folk JE, (1988) Free and protein-conjugated polyamines in mouse epidermal cells. Effect of high calcium and retinoic acid. J Biol Chem 263, 3790-3794. (Pubitemid 18078968)
58. Walther DJ, Stahlberg S, &, Vowinckel J, (2011) Novel roles for biogenic monamines: from monoamines in transglutaminase-mediated post-translational protein modification to monoaminylation deregulation diseases. FEBS J 278, 4740-4755.
59. Groenen PJ, Bloemendal H, &, de Jong WW, (1992) The carboxy-terminal lysine of alpha B-crystallin is an amine-donor substrate for tissue transglutaminase. Eur J Biochem 205, 671-674.
60. Yamane A, Fukui M, Sugimura Y, Itoh M, Alea MP, Thomas V, El Alaoui S, Akiyama M, &, Hitomi K, (2010) Identification of a preferred substrate peptide for transglutaminase 3 and detection of in situ activity in skin and hair follicles. FEBS J 277, 3564-3574.
61. Itoh M, Kawamoto T, Tatsukawa H, Kojima S, Yamanishi K, &, Hitomi K, (2011) In situ detection of active transglutaminases for keratinocyte-type (TGase 1) and tissue-type (TGase 2) using fluorescence-labeled highly reactive substrate peptides. J Histochem Cytochem 59, 180-187.
62. Dafik L, &, Khosla C, (2011) Dihydroisoxazole analogs for labeling and visualization of catalytically active transglutaminase 2. Chem Biol 18, 58-66.
63. el Alaoui S, Legastelois S, Roch AM, Chantepie J, &, Quash G, (1991) Transglutaminase activity and N epsilon (gamma glutamyl) lysine isopeptide levels during cell growth: an enzymic and immunological study. Int J Cancer 48, 221-226.
64. Johnson GV, &, LeShoure R Jr, (2004) Immunoblot analysis reveals that isopeptide antibodies do not specifically recognize the epsilon-(gamma- glutamyl)lysine bonds formed by transglutaminase activity. J Neurosci Methods 134, 151-158. (Pubitemid 38299241)
65. Folk JE, Park MH, Chung SI, Schrode J, Lester EP, &, Cooper HL, (1980) Polyamines as physiological substrates for transglutaminases. J Biol Chem 255, 3695-3700.
66. Lesort M, Tucholski J, Zhang J, &, Johnson GV, (2000) Impaired mitochondrial function results in increased tissue transglutaminase activity in situ. J Neurochem 75, 1951-1961.
67. Lee KN, Maxwell MD, Patterson MK Jr, Birckbichler PJ, &, Conway E, (1992) Identification of transglutaminase substrates in HT29 colon cancer cells: use of 5-(biotinamido)pentylamine as a transglutaminase-specific probe. Biochim Biophys Acta 1136, 12-16.
68. Parwaresch MR, Radzun HJ, Bödewadt S, Frendel A, Sundström C, &, Lennert K, (1984) Alternative myelomonocytic differentiation of HL-60 reflects dual prospective potency of promyelocytes in human. Cell Immunol 89, 385-398. (Pubitemid 15198340)
69. Lorand L, Murthy SN, Velasco PT, &, Karush F, (1986) Identification of transglutaminase substrates in inside-out vesicles from human erythrocytes: immunoblotting with anti-dansyl antibody. Biochem Biophys Res Commun 134, 685-689. (Pubitemid 16070551)
70. Shin DM, Jeon JH, Kim CW, Cho SY, Kwon JC, Lee HJ, Choi KH, Park SC, &, Kim IG, (2004) Cell type-specific activation of intracellular transglutaminase 2 by oxidative stress or ultraviolet irradiation: implications of transglutaminase 2 in age-related cataractogenesis. J Biol Chem 279, 15032-15039.
71. Nemes Z Jr, Adány R, Balázs M, Boross P, &, Fésüs L, (1997) Identification of cytoplasmic actin as an abundant glutaminyl substrate for tissue transglutaminase in HL-60 and U937 cells undergoing apoptosis. J Biol Chem 272, 20577-20583. (Pubitemid 27355616)
72. Jeon JH, Kim CW, Shin DM, Kim K, Cho SY, Kwon JC, Choi KH, Kang HS, &, Kim IG, (2003) Differential incorporation of biotinylated polyamines by transglutaminase 2. FEBS Lett 534, 180-184. (Pubitemid 36084539)
73. Lorand L, (1998) DRPLA aggregation and transglutaminase, revisited. Nat Genet 20, 231.
74. Contreras L, Drago I, Zampese E, &, Pozzan T, (2010) Mitochondria: the calcium connection. Biochim Biophys Acta 1797, 607-618.
75. Llinas R, Sugimori M, &, Silver RB, (1992) Microdomains of high calcium concentration in a presynaptic terminal. Science 256, 677-679.
76. Paulmann N, Grohmann M, Voigt JP, Bert B, Vowinckel J, Bader M, Skelin M, Jevsek M, Fink H, Rupnik M, et al. (2009) Intracellular serotonin modulates insulin secretion from pancreatic beta-cells by protein serotonylation. PLoS Biol 7, e1000229.
77. Soria B, Tudurí E, González A, Hmadcha A, Martin F, Nadal A, &, Quesada I, (2010) Pancreatic islet cells: a model for calcium-dependent peptide release. HFSP J 4, 52-60.
78. Steinert PM, Candi E, Tarcsa E, Marekov LN, Sette M, Paci M, Ciani B, Guerrieri P, &, Melino G, (1999) Transglutaminase crosslinking and structural studies of the human small proline rich 3 protein. Cell Death Differ 6, 916-930. (Pubitemid 29488090)
79. Balajthy Z, Csomós K, Vámosi G, Szántó A, Lanotte M, &, Fésüs L, (2006) Tissue-transglutaminase contributes to neutrophil granulocyte differentiation and functions. Blood 108, 2045-2054. (Pubitemid 44395020)
80. Csomós K, Német I, Fésüs L, &, Balajthy Z, (2010) Tissue transglutaminase contributes to the all-trans retinoic acid induced differentiation syndrome phenotype in the NB4 model of acute promyelocytic leukemia. Blood 116, 3933-3943.
81. Zheng PZ, Wang KK, Zhang QY, Huang QH, Du YZ, Zhang QH, Xiao DK, Shen SH, Imbeaud S, Eveno E, et al. (2005) Systems analysis of transcriptome and proteome in retinoic acid/arsenic trioxide-induced cell differentiation/ apoptosis of promyelocytic leukemia. Proc Natl Acad Sci USA 102, 7653-7658. (Pubitemid 40741026)
82. Peitsch MC, Polzar B, Stephan H, Crompton T, MacDonald HR, Mannherz HG, &, Tschopp J, (1993) Characterization of the endogenous deoxyribonuclease involved in nuclear DNA degradation during apoptosis (programmed cell death). EMBO J 12, 371-377. (Pubitemid 23042417)
83. Verhoven B, Schlegel RA, &, Williamson P, (1995) Mechanisms of phosphatidylserine exposure, a phagocyte recognition signal, on apoptotic T lymphocytes. J Exp Med 182, 1597-1601.
84. Fesus L, Thomazy V, &, Falus A, (1987) Induction and activation of tissue transglutaminase during programmed cell death. FEBS Lett 224, 104-108. (Pubitemid 17159992)
85. Fesus L, Thomazy V, Autuori F, Ceru MP, Tarcsa E, &, Piacentini M, (1989) Apoptotic hepatocytes become insoluble in detergents and chaotropic agents as a result of transglutaminase action. FEBS Lett 245, 150-154. (Pubitemid 19076220)
86. -/- mice reveal a phagocytosis-associated crosstalk between macrophages and apoptotic cells. Proc Natl Acad Sci USA 100, 7812-7817. (Pubitemid 36760052)
87. Nicholas B, Smethurst P, Verderio E, Jones R, &, Griffin M, (2003) Cross-linking of cellular proteins by tissue transglutaminase during necrotic cell death: a mechanism for maintaining tissue integrity. Biochem J 371, 413-422. (Pubitemid 36547624)
88. Fesus L, &, Szondy Z, (2005) Transglutaminase 2 in the balance of cell death and survival. FEBS Lett 579, 3297-3302. (Pubitemid 40804677)
89. Gundemir S, &, Johnson GV, (2009) Intracellular localization and conformational state of transglutaminase 2: implications for cell death. PLoS ONE 4, e6123.
90. Kuo TF, Tatsukawa H, &, Kojima S, (2011) New insights into functions and localization of nuclear transglutaminase 2. FEBS J 278, 4756-4767.
91. Antonyak MA, Li B, Regan AD, Feng Q, Dusaban SS, &, Cerione RA, (2009) Tissue transglutaminase is an essential participant in the epidermal growth factor-stimulated signaling pathway leading to cancer cell migration and invasion. J Biol Chem 284, 17914-17925.
92. Singh US, &, Cerione RA, (1996) Biochemical effects of retinoic acid on GTP-binding protein/transglutaminases in HeLa cells. Stimulation of GTP-binding and transglutaminase activity, membrane association, and phosphatidylinositol lipid turnover. J Biol Chem 271, 27292-27298. (Pubitemid 26367282)
93. Lai TS, Bielawska A, Peoples KA, Hannun YA, &, Greenberg CS, (1997) Sphingosylphosphocholine reduces the calcium ion requirement for activating tissue transglutaminase. J Biol Chem 272, 16295-16300. (Pubitemid 27276451)
94. Sturniolo MT, Chandraratna RA, &, Eckert RL, (2005) A novel transglutaminase activator forms a complex with type 1 transglutaminase. Oncogene 24, 2963-2972. (Pubitemid 40675527)
95. Facchiano F, &, Luini A, (1992) Tetanus toxin potently stimulates tissue transglutaminase. A possible mechanism of neurotoxicity. J Biol Chem 267, 13267-13271.
96. Feng JF, Readon M, Yadav SP, &, Im MJ, (1999) Calreticulin down-regulates both GTP binding and transglutaminase activities of transglutaminase II. Biochemistry 38, 10743-10749.
97. Yi SJ, Groffen J, &, Heisterkamp N, (2009) Transglutaminase 2 regulates the GTPase-activating activity of Bcr. J Biol Chem 284, 35645-35651.
98. Harsfalvi J, Arato G, &, Fesus L, (1987) Lipids associated with tissue transglutaminase. Biochim Biophys Acta 923, 42-45. (Pubitemid 17229887)
99. Fésüs L, Horváth A, &, Hársfalvi J, (1983) Interaction between tissue transglutaminase and phospholipid vesicles. FEBS Lett 155, 1-5.
100. Tóth B, Garabuczi E, Sarang Z, Vereb G, Vámosi G, Aeschlimann D, Blaskó B, Bécsi B, Erdõdi F, Lacy-Hulbert A, et al. (2009) Transglutaminase 2 is needed for the formation of an efficient phagocyte portal in macrophages engulfing apoptotic cells. J Immunol 182, 2084-2092.
101. Rodolfo C, Mormone E, Matarrese P, Ciccosanti F, Farrace MG, Garofano E, Piredda L, Fimia GM, Malorni W, &, Piacentini M, (2004) Tissue transglutaminase is a multifunctional BH3-only protein. J Biol Chem 279, 54783-54792. (Pubitemid 40053223)
102. Park D, Choi SS, &, Ha KS, (2010) Transglutaminase 2: a multi-functional protein in multiple subcellular compartments. Amino Acids 39, 619-631.
103. D'Eletto M, Farrace MG, Falasca L, Reali V, Oliverio S, Melino G, Griffin M, Fimia GM, &, Piacentini M, (2009) Transglutaminase 2 is involved in autophagosome maturation. Autophagy 5, 1145-1154.
104. Walther DJ, Peter JU, Winter S, Höltje M, Paulmann N, Grohmann M, Vowinckel J, Alamo-Bethencourt V, Wilhelm CS, Ahnert-Hilger G, et al. (2003) Serotonylation of small GTPases is a signal transduction pathway that triggers platelet alpha-granule release. Cell 115, 851-862. (Pubitemid 38058497)
105. Nemes Z, Petrovski G, Aerts M, Sergeant K, Devreese B, &, Fésüs L, (2009) Transglutaminase-mediated intramolecular cross-linking of membrane-bound alpha-synuclein promotes amyloid formation in Lewy bodies. J Biol Chem 284, 27252-27264.
106. Flavell SW, &, Greenberg ME, (2008) Signaling mechanisms linking neuronal activity to gene expression and plasticity of the nervous system. Annu Rev Neurosci 31, 563-590.
107. Neher E, &, Sakaba T, (2008) Multiple roles of calcium ions in the regulation of neurotransmitter release. Neuron 59, 861-872.
108. Fraij BM, &, Gonzales RA, (1997) Organization and structure of the human tissue transglutaminase gene. Biochim Biophys Acta 1354, 65-71. (Pubitemid 27479896)
109. Fraij BM, Birckbichler PJ, Patterson MK Jr, Lee KN, &, Gonzales RA, (1992) A retinoic acid-inducible mRNA from human erythroleukemia cells encodes a novel tissue transglutaminase homologue. J Biol Chem 267, 22616-22623.
110. Fraij BM, (1996) GTP hydrolysis by human tissue transglutaminase homologue. Biochem Biophys Res Commun 218, 45-49. (Pubitemid 26034486)
111. Monsonego A, Shani Y, Friedmann I, Paas Y, Eizenberg O, &, Schwartz M, (1997) Expression of GTP-dependent and GTP-independent tissue-type transglutaminase in cytokine-treated rat brain astrocytes. J Biol Chem 272, 3724-3732.
112. Fraij BM, &, Gonzales RA, (1996) A third human tissue transglutaminase homologue as a result of alternative gene transcripts. Biochim Biophys Acta 1306, 63-74. (Pubitemid 26120715)
113. Citron BA, SantaCruz KS, Davies PJ, &, Festoff BW, (2001) Intron-exon swapping of transglutaminase mRNA and neuronal Tau aggregation in Alzheimer's disease. J Biol Chem 276, 3295-3301.
114. Festoff BW, SantaCruz K, Arnold PM, Sebastian CT, Davies PJ, &, Citron BA, (2002) Injury-induced 'switch' from GTP-regulated to novel GTP-independent isoform of tissue transglutaminase in the rat spinal cord. J Neurochem 81, 708-718. (Pubitemid 34809300)
115. Lai TS, Liu Y, Li W, &, Greenberg CS, (2007) Identification of two GTP-independent alternatively spliced forms of tissue transglutaminase in human leukocytes, vascular smooth muscle, and endothelial cells. FASEB J 21, 4131-4143. (Pubitemid 350232370)
116. Tsai YH, Lai WF, Chen SH, &, Johnson LR, (1998) A novel calcium-independent enzyme capable of incorporating putrescine into proteins. Biochem Biophys Res Commun 244, 161-166. (Pubitemid 28419917)
117. Tsai YH, Lai WF, Wu YW, &, Johnson LR, (1998) Two distinct classes of rat intestinal mucosal enzymes incorporating putrescine into protein. FEBS Lett 435, 251-256. (Pubitemid 28435011)
118. Antonyak MA, Jansen JM, Miller AM, Ly TK, Endo M, &, Cerione RA, (2006) Two isoforms of tissue transglutaminase mediate opposing cellular fates. Proc Natl Acad Sci USA 103, 18609-18614. (Pubitemid 44913458)
119. Byrne G, Feighery C, Jackson J, &, Kelly J, (2010) Coeliac disease autoantibodies mediate significant inhibition of tissue transglutaminase. Clin Immunol 136, 426-431.
120. Nemes Z, Devreese B, Steinert PM, Van Beeumen J, &, Fésüs L, (2004) Cross-linking of ubiquitin, HSP27, parkin, and alpha-synuclein by gamma-glutamyl-epsilon-lysine bonds in Alzheimer's neurofibrillary tangles. FASEB J 18, 1135-1137. (Pubitemid 39561548)
121. Jeitner TM, Muma NA, Battaile KP, &, Cooper AJ, (2009) Transglutaminase activation in neurodegenerative diseases. Future Neurol 4, 449-467.
122. Busche MA, Eichhoff G, Adelsberger H, Abramowski D, Wiederhold KH, Haass C, Staufenbiel M, Konnerth A, &, Garaschuk O, (2008) Clusters of hyperactive neurons near amyloid plaques in a mouse model of Alzheimer's disease. Science 321, 1686-1689.
123. Kuchibhotla KV, Goldman ST, Lattarulo CR, Wu HY, Hyman BT, &, Bacskai BJ, (2008) Abeta plaques lead to aberrant regulation of calcium homeostasis in vivo resulting in structural and functional disruption of neuronal networks. Neuron 59, 214-225. (Pubitemid 352033686)
124. Bezprozvanny I, &, Mattson MP, (2008) Neuronal calcium mishandling and the pathogenesis of Alzheimer's disease. Trends Neurosci 31, 454-463.
125. 2+ leak channels, a function disrupted by familial Alzheimer's disease-linked mutations. Cell 126, 981-993. (Pubitemid 44310781)
126. 2+ leak function of presenilin 1. J Clin Invest 117, 1230-1239. (Pubitemid 46718411)
127. Camandola S, &, Mattson MP, (2010) Aberrant subcellular neuronal calcium regulation in aging and Alzheimer's disease. Biochim Biophys Acta, 1813, 965-973.
128. Thibault O, Gant JC, &, Landfield PW, (2007) Expansion of the calcium hypothesis of brain aging and Alzheimer's disease: minding the store. Aging Cell 6, 307-317. (Pubitemid 46785136)
129. Mastroberardino PG, Iannicola C, Nardacci R, Bernassola F, De Laurenzi V, Melino G, Moreno S, Pavone F, Oliverio S, Fesus L, et al. (2002) 'Tissue' transglutaminase ablation reduces neuronal death and prolongs survival in a mouse model of Huntington's disease. Cell Death Differ 9, 873-880. (Pubitemid 35023603)
130. Zhang H, Das S, Li QZ, Dragatsis I, Repa J, Zeitlin S, Hajnóczky G, &, Bezprozvanny I, (2008) Elucidating a normal function of huntingtin by functional and microarray analysis of huntingtin-null mouse embryonic fibroblasts. BMC Neurosci 9, 38.
131. Tang TS, Tu H, Chan EY, Maximov A, Wang Z, Wellington CL, Hayden MR, &, Bezprozvanny I, (2003) Huntingtin and huntingtin-associated protein 1 influence neuronal calcium signaling mediated by inositol-(1,4,5) triphosphate receptor type 1. Neuron 39, 227-239. (Pubitemid 36897546)
132. Zeron MM, Hansson O, Chen N, Wellington CL, Leavitt BR, Brundin P, Hayden MR, &, Raymond LA, (2002) Increased sensitivity to N-methyl-D-aspartate receptor-mediated excitotoxicity in a mouse model of Huntington's disease. Neuron 33, 849-860. (Pubitemid 34246352)
133. Tang TS, Guo C, Wang H, Chen X, &, Bezprozvanny I, (2009) Neuroprotective effects of inositol 1,4,5-trisphosphate receptor C-terminal fragment in a Huntington's disease mouse model. J Neurosci 29, 1257-1266.
134. Panov AV, Gutekunst CA, Leavitt BR, Hayden MR, Burke JR, Strittmatter WJ, &, Greenamyre JT, (2002) Early mitochondrial calcium defects in Huntington's disease are a direct effect of polyglutamines. Nat Neurosci 5, 731-736. (Pubitemid 34827590)
135. Milakovic T, Quintanilla RA, &, Johnson GV, (2006) Mutant huntingtin expression induces mitochondrial calcium handling defects in clonal striatal cells: functional consequences. J Biol Chem 281, 34785-34795. (Pubitemid 46036517)
136. Choi YM, Kim SH, Uhm DY, &, Park MK, (2003) Glutamate-mediated [Ca2+]c dynamics in spontaneously firing dopamine neurons of the rat substantia nigra pars compacta. J Cell Sci 116 (Pt 13), 2665-2675. (Pubitemid 36857220)
137. Surmeier DJ, (2007) Calcium, ageing, and neuronal vulnerability in Parkinson's disease. Lancet Neurol 6, 933-938. (Pubitemid 47405004)
138. Strnad P, Harada M, Siegel M, Terkeltaub RA, Graham RM, Khosla C, &, Omary MB, (2007) Transglutaminase 2 regulates mallory body inclusion formation and injury-associated liver enlargement. Gastroenterology 132, 1515-1526. (Pubitemid 46627586)
139. Yan M, Zhu P, Liu HM, Zhang HT, &, Liu L, (2007) Ethanol induced mitochondria injury and permeability transition pore opening: role of mitochondria in alcoholic liver disease. World J Gastroenterol 13, 2352-2356. (Pubitemid 46860738)
140. Lorand L, Hsu LK, Siefring GE Jr, &, Rafferty NS, (1981) Lens transglutaminase and cataract formation. Proc Natl Acad Sci USA 78, 1356-1360. (Pubitemid 11112135)
141. Berbers GA, Bentlage HC, Brans AM, Bloemendal H, &, de Jong WW, (1983) beta-Crystallin: endogenous substrate of lens transglutaminase. Characterization of the acyl-donor site in the beta Bp chain. Eur J Biochem 135, 315-320. (Pubitemid 14237953)
142. 2+-induced protein loss, vimentin cleavage and opacification. Invest Ophthalmol Vis Sci 41, 2255-2561.
143. 2+ and ROS. Front Biosci 14, 1197-1218.
144. Luciani A, Villella VR, Vasaturo A, Giardino I, Raia V, Pettoello-Mantovani M, D'Apolito M, Guido S, Leal T, Quaratino S, et al. (2009) SUMOylation of tissue transglutaminase as link between oxidative stress and inflammation. J Immunol 183, 2775-2784.
145. Luciani A, Villella VR, Esposito S, Brunetti-Pierri N, Medina D, Settembre C, Gavina M, Pulze L, Giardino I, Pettoello-Mantovani M, et al. (2010) Defective CFTR induces aggresome formation and lung inflammation in cystic fibrosis through ROS-mediated autophagy inhibition. Nat Cell Biol 12, 863-875.
146. Maiuri L, Luciani A, Giardino I, Raia V, Villella VR, D'Apolito M, Pettoello-Mantovani M, Guido S, Ciacci C, Cimmino M, et al. (2008) Tissue transglutaminase activation modulates inflammation in cystic fibrosis via PPARgamma down-regulation. J Immunol 180, 7697-7705.
147. Folk JE, &, Cole PW, (1966) Mechanism of action of guinea pig liver transglutaminase. I. Purification and properties of the enzyme: identification of a functional cysteine essential for activity. J Biol Chem 241, 5518-5525.
148. Gentile V, Saydak M, Chiocca EA, Akande O, Birckbichler PJ, Lee KN, Stein JP, &, Davies PJ, (1991) Isolation and characterization of cDNA clones to mouse macrophage and human endothelial cell tissue transglutaminases. J Biol Chem 266, 478-483. (Pubitemid 21906147)
149. Boehm JE, Singh U, Combs C, Antonyak MA, &, Cerione RA, (2002) Tissue transglutaminase protects against apoptosis by modifying the tumor suppressor protein p110 Rb. J Biol Chem 277, 20127-20130. (Pubitemid 34967301)
150. Tucholski J, Lesort M, &, Johnson GV, (2001) Tissue transglutaminase is essential for neurite outgrowth in human neuroblastoma SH-SY5Y cells. Neuroscience 102, 481-491. (Pubitemid 32126502)
151. Singh US, Pan J, Kao YL, Joshi S, Young KL, &, Baker KM, (2003) Tissue transglutaminase mediates activation of RhoA and MAP kinase pathways during retinoic acid-induced neuronal differentiation of SH-SY5Y cells. J Biol Chem 278, 391-399. (Pubitemid 36043588)
152. Tee AE, Marshall GM, Liu PY, Xu N, Haber M, Norris MD, Iismaa SE, &, Liu T, (2010) Opposing effects of two tissue transglutaminase protein isoforms in neuroblastoma cell differentiation. J Biol Chem 285, 3561-3567.
153. Satpathy M, Shao M, Emerson R, Donner DB, &, Matei D, (2009) Tissue transglutaminase regulates matrix metalloproteinase-2 in ovarian cancer by modulating cAMP-response element-binding protein activity. J Biol Chem 284, 15390-15399.
154. Tucholski J, &, Johnson GV, (2003) Tissue transglutaminase directly regulates adenylyl cyclase resulting in enhanced cAMP-response element-binding protein (CREB) activation. J Biol Chem 278, 26838-26843. (Pubitemid 36876834)
155. Singh US, Kunar MT, Kao YL, &, Baker KM, (2001) Role of transglutaminase II in retinoic acid-induced activation of RhoA-associated kinase-2. EMBO J 20, 2413-2423. (Pubitemid 32452859)
156. Owen RA, Bungay PJ, Hussain M, &, Griffin M, (1988) Transglutaminase-catalysed cross-linking of proteins phosphorylated in the intact glucose-stimulated pancreatic beta-cell. Biochim Biophys Acta 968, 220-230. (Pubitemid 18078339)
157. Dai Y, Dudek NL, Li Q, &, Muma NA, (2010) Phospholipase C, Ca(2+), and calmodulin signaling are required for 5-HT(2A) receptor-mediated transamidation of Rac1 by transglutaminase. Psychopharmacology (Berl), 213, 403-412.
158. Dai Y, Dudek NL, Patel TB, &, Muma NA, (2008) Transglutaminase- catalyzed transamidation: a novel mechanism for Rac1 activation by 5-hydroxytryptamine2A receptor stimulation. J Pharmacol Exp Ther 326, 153-162. (Pubitemid 351872143)
159. Yi SJ, Groffen J, &, Heisterkamp N, (2011) Bcr is a substrate for transglutaminase 2 cross-linking activity. BMC Biochem 12, 8.
160. Alcock J, Warren AY, Goodson YJ, Hill SJ, Khan RN, &, Lymn JS, (2011) Inhibition of transglutaminase 2 attenuates contractility of pregnant human myometrium. Biol Reprod 84, 646-653.
161. Lee J, Kim YS, Choi DH, Bang MS, Han TR, Joh TH, &, Kim SY, (2004) Transglutaminase 2 induces nuclear factor-kappaB activation via a novel pathway in BV-2 microglia. J Biol Chem 279, 53725-53735. (Pubitemid 40051881)
162. Park SS, Kim JM, Kim DS, Kim IH, &, Kim SY, (2006) Transglutaminase 2 mediates polymer formation of I-kappaBalpha through C-terminal glutamine cluster. J Biol Chem 281, 34965-34972.
163. Kim DS, Han BG, Park KS, Lee BI, Kim SY, &, Bae CD, (2010) I-kappaBalpha depletion by transglutaminase 2 and mu-calpain occurs in parallel with the ubiquitin-proteasome pathway. Biochem Biophys Res Commun 399, 300-306.
164. Jang GY, Jeon JH, Cho SY, Shin DM, Kim CW, Jeong EM, Bae HC, Kim TW, Lee SH, Choi Y, et al. (2010) Transglutaminase 2 suppresses apoptosis by modulating caspase 3 and NF-kappaB activity in hypoxic tumor cells. Oncogene 29, 356-367.
165. Kim DS, Kim B, Tahk H, Kim DH, Ahn ER, Choi C, Jeon Y, Park SY, Lee H, Oh SH, et al. (2010) Transglutaminase 2 gene ablation protects against renal ischemic injury by blocking constant NF-κB activation. Biochem Biophys Res Commun 403, 479-484.
166. Park KS, Kim DS, Ko C, Lee SJ, Oh SH, &, Kim SY, (2011) TNF-alpha mediated NF-kappaB activation is constantly extended by transglutaminase 2. Front Biosci 3, 341-354.
167. Tatsukawa H, Fukaya Y, Frampton G, Martinez-Fuentes A, Suzuki K, Kuo TF, Nagatsuma K, Shimokado K, Okuno M, Wu J, et al. (2009) Role of transglutaminase 2 in liver injury via cross-linking and silencing of transcription factor Sp1. Gastroenterology 136, 1783-1795. e10.
168. Datta S, Antonyak MA, &, Cerione RA, (2006) Importance of Ca(2+)-dependent transamidation activity in the protection afforded by tissue transglutaminase against doxorubicin-induced apoptosis. Biochemistry 45, 13163-13174. (Pubitemid 44707677)
169. Zatloukal K, Fesus L, Denk H, Tarcsa E, Spurej G, &, Böck G, (1992) High amount of epsilon-(gamma-glutamyl)lysine cross-links in Mallory bodies. Lab Invest 66, 774-777.
170. Igarashi S, Koide R, Shimohata T, Yamada M, Hayashi Y, Takano H, Date H, Oyake M, Sato T, Sato A, et al. (1998) Suppression of aggregate formation and apoptosis by transglutaminase inhibitors in cells expressing truncated DRPLA protein with an expanded polyglutamine stretch. Nat Genet 18, 111-117. (Pubitemid 28082456)
171. McConoughey SJ, Basso M, Niatsetskaya ZV, Sleiman SF, Smirnova NA, Langley BC, Mahishi L, Cooper AJ, Antonyak MA, Cerione RA, et al. (2010) Inhibition of transglutaminase 2 mitigates transcriptional dysregulation in models of Huntington disease. EMBO Mol Med 2, 349-370.
172. Jeon JH, Choi KH, Cho SY, Kim CW, Shin DM, Kwon JC, Song KY, Park SC, &, Kim IG, (2003) Transglutaminase 2 inhibits Rb binding of human papillomavirus E7 by incorporating polyamine. EMBO J 22, 5273-5282.
173. Lee ZW, Kwon SM, Kim SW, Yi SJ, Kim YM, &, Ha KS, (2003) Activation of in situ tissue transglutaminase by intracellular reactive oxygen species. Biochem Biophys Res Commun 305, 633-640.
174. Li B, Antonyak MA, Druso JE, Cheng L, Nikitin AY, &, Cerione RA, (2010) EGF potentiated oncogenesis requires a tissue transglutaminase-dependent signaling pathway leading to Src activation. Proc Natl Acad Sci USA 107, 1408-1413.
175. Malorni W, Farrace MG, Matarrese P, Tinari A, Ciarlo L, Mousavi-Shafaei P, D'Eletto M, Di Giacomo G, Melino G, &, Palmieri L, (2009) The adenine nucleotide translocator 1 acts as a type 2 transglutaminase substrate: implications for mitochondrial-dependent apoptosis free. Cell Death Differ 16, 1480-1492.
176. Frese-Schaper M, Schardt JA, Sakai T, Carboni GL, Schmid RA, &, Frese S, (2010) Inhibition of tissue transglutaminase sensitizes TRAIL-resistant lung cancer cells through upregulation of death receptor 5. FEBS Lett 584, 2867-2871.